These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 32883618)
1. Development and validation of prescription drug risk, efficacy, and benefit perception measures in the context of direct-to-consumer prescription drug advertising. Kelly BJ; Rupert DJ; Aikin KJ; Sullivan HW; Johnson M; Bann CM; Mack N; Southwell BG; West S; Parvanta S; Rabre A; Peinado S Res Social Adm Pharm; 2021 May; 17(5):942-955. PubMed ID: 32883618 [TBL] [Abstract][Full Text] [Related]
2. Correction of misleading information in prescription drug television advertising: The roles of advertisement similarity and time delay. Aikin KJ; Southwell BG; Paquin RS; Rupert DJ; O'Donoghue AC; Betts KR; Lee PK Res Social Adm Pharm; 2017; 13(2):378-388. PubMed ID: 27178746 [TBL] [Abstract][Full Text] [Related]
3. Visual presentations of efficacy data in direct-to-consumer prescription drug print and television advertisements: A randomized study. Sullivan HW; O'Donoghue AC; Aikin KJ; Chowdhury D; Moultrie RR; Rupert DJ Patient Educ Couns; 2016 May; 99(5):790-9. PubMed ID: 26749356 [TBL] [Abstract][Full Text] [Related]
4. The Effect of Including Quantitative Information on Multiple Endpoints in Direct-to-Consumer Prescription Drug Television Advertisements. Sullivan HW; O'Donoghue AC; Lynch M; Johnson M; Davis C; Rupert DJ Med Decis Making; 2019 Nov; 39(8):975-985. PubMed ID: 31583947 [No Abstract] [Full Text] [Related]
5. Visual images of prescription drug benefits in direct-to-consumer television advertisements. Sullivan HW; O'Donoghue AC; Lynch M; Johnson M; Davis C; Amoozegar JB; Rupert DJ Patient Educ Couns; 2021 Sep; 104(9):2240-2249. PubMed ID: 33618970 [TBL] [Abstract][Full Text] [Related]
6. Communicating efficacy information based on composite scores in direct-to-consumer prescription drug advertising. Williams PA; O'Donoghue AC; Sullivan HW; Willoughby JF; Squire C; Parvanta S; Betts KR Patient Educ Couns; 2016 Apr; 99(4):583-590. PubMed ID: 26589655 [TBL] [Abstract][Full Text] [Related]
7. Effects of comparative claims in prescription drug direct-to-consumer advertising on consumer perceptions and recall. O'Donoghue AC; Williams PA; Sullivan HW; Boudewyns V; Squire C; Willoughby JF Soc Sci Med; 2014 Nov; 120():1-11. PubMed ID: 25194471 [TBL] [Abstract][Full Text] [Related]
8. 'At-risk' individuals' responses to direct to consumer advertising of prescription drugs: a nationally representative cross-sectional study. Khalil Zadeh N; Robertson K; Green JA BMJ Open; 2017 Dec; 7(12):e017865. PubMed ID: 29217723 [TBL] [Abstract][Full Text] [Related]
9. Serious and actionable risks, plus disclosure: Investigating an alternative approach for presenting risk information in prescription drug television advertisements. Betts KR; Boudewyns V; Aikin KJ; Squire C; Dolina S; Hayes JJ; Southwell BG Res Social Adm Pharm; 2018 Oct; 14(10):951-963. PubMed ID: 28844621 [TBL] [Abstract][Full Text] [Related]
10. Consumer perceptions of prescription and over-the-counter drug advertisements with promotional offers. Aikin KJ; Sullivan HW; O'Donoghue AC; Betts KR Health Mark Q; 2016; 33(4):291-306. PubMed ID: 27841741 [TBL] [Abstract][Full Text] [Related]
11. Fair Balance and Adequate Provision in Direct-to-Consumer Prescription Drug Online Banner Advertisements: A Content Analysis. Adams C J Med Internet Res; 2016 Feb; 18(2):e33. PubMed ID: 26892749 [TBL] [Abstract][Full Text] [Related]
12. Presenting efficacy information in direct-to-consumer prescription drug advertisements. O'Donoghue AC; Sullivan HW; Aikin KJ; Chowdhury D; Moultrie RR; Rupert DJ Patient Educ Couns; 2014 May; 95(2):271-80. PubMed ID: 24581929 [TBL] [Abstract][Full Text] [Related]
13. Consumer tradeoff of advertising claim versus efficacy information in direct-to-consumer prescription drug ads. Aikin KJ; Betts KR; Ziemer KS; Keisler A Res Social Adm Pharm; 2019 Dec; 15(12):1484-1488. PubMed ID: 30846370 [TBL] [Abstract][Full Text] [Related]
14. Disease Information in Direct-to-Consumer Prescription Drug Print Ads. Aikin KJ; Sullivan HW; Betts KR J Health Commun; 2016; 21(2):228-39. PubMed ID: 26717304 [TBL] [Abstract][Full Text] [Related]
15. Attention to price disclosures in direct-to-consumer prescription drug advertising and the impact on drug perceptions. Ball JG; Hollin IL Res Social Adm Pharm; 2022 Aug; 18(8):3402-3413. PubMed ID: 34819265 [TBL] [Abstract][Full Text] [Related]
17. Perceptions of Direct-to-Consumer Advertising and the Older Adult Population. Bailey TA; Fenney M Consult Pharm; 2016 Apr; 31(4):215-20. PubMed ID: 27056358 [TBL] [Abstract][Full Text] [Related]
18. Consumer responses to framing statements preceding the major risk statement in prescription drug DTC TV ads. Aikin KJ; Betts KR; Boudewyns V; Johnson M; Davis CN Res Social Adm Pharm; 2020 Sep; 16(9):1237-1247. PubMed ID: 31838056 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of Risk Versus Benefit Information in Direct-To-Consumer (DTC) Prescription Drug Television Advertisements. Fahim G; Toscani M; Barone JA; Wang C; Gandhi S Ther Innov Regul Sci; 2018 Jan; 52(1):114-117. PubMed ID: 29714616 [TBL] [Abstract][Full Text] [Related]
20. Individual- and Ad-Level Predictors of Perceptions of Serious and Actionable Risks in Direct-to-Consumer Prescription Drug TV Advertising. Aikin KJ; Boudewyns V; Betts KR; Southwell BG; Williams P J Health Commun; 2019; 24(5):536-546. PubMed ID: 31253071 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]